Josephine Brysting

Phd Fellow @EMBL

An epigenetics approach to the discovery of novel targets (‘neotargets’) for next generation immunotherapies in acute myeloid leukemia. Co-supervised within the Molecular Medicine Partnership Unit (MMPU) by: • Prof. Dr. Carsten Müller-Tidow (epigenomics, epitranscriptomics and novel therapy approaches in AML, Heidelberg University Hospital). Group URL: • Dr. Judith Zaugg (stem cell niche networks, EMBL). Group URL: Amongst the ~2.7% of applicants accepted to the 2021 EMBL International PhD Programme (EIPP). We are represented by~50 nationalities across 5 sites in an extensive network of collaborations.